Waters
NYSE:WAT Community- 1 Narratives written by author
- 0 Comments on narratives written by author
- 18 Fair Values set on narratives written by author
WA
Consensus Narrative from 19 Analysts
Focusing On Biologics And PFAS Testing Will Improve Future Prospects
Key Takeaways Strategic focus on high-growth areas like biologics and PFAS testing positions Waters for increased revenue and market share expansion. Operational improvements enhance margins, while macroeconomic recovery and deferred replacements boost sales and earnings growth.
View narrativeUS$392.11
FV
4.4% undervalued intrinsic discount5.61%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
3users have followed this narrative
24 days ago author updated this narrative